Voyageur Pharmaceuticals Stock Market Value
| VYYRF Stock | USD 0.13 0.00 0.00% |
| Symbol | Voyageur |
Voyageur Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Voyageur Pharmaceuticals' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Voyageur Pharmaceuticals.
| 12/22/2025 |
| 01/21/2026 |
If you would invest 0.00 in Voyageur Pharmaceuticals on December 22, 2025 and sell it all today you would earn a total of 0.00 from holding Voyageur Pharmaceuticals or generate 0.0% return on investment in Voyageur Pharmaceuticals over 30 days. Voyageur Pharmaceuticals is related to or competes with Avicanna, Charlottes Web, Raphael Pharmaceutical, Izotropic, and Rubicon Organics. Voyageur Pharmaceuticals Ltd. focuses on the development of active pharmaceutical ingredients minerals More
Voyageur Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Voyageur Pharmaceuticals' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Voyageur Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1214 | |||
| Maximum Drawdown | 2930.3 | |||
| Potential Upside | 15.79 |
Voyageur Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Voyageur Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Voyageur Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Voyageur Pharmaceuticals historical prices to predict the future Voyageur Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0987 | |||
| Jensen Alpha | 43.5 | |||
| Total Risk Alpha | 12.15 | |||
| Treynor Ratio | 7.4 |
Voyageur Pharmaceuticals Backtested Returns
Voyageur Pharmaceuticals is out of control given 3 months investment horizon. Voyageur Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.12, which indicates the firm had a 0.12 % return per unit of risk over the last 3 months. We were able to interpolate data for seventeen different technical indicators, which can help you to evaluate if expected returns of 15.34% are justified by taking the suggested risk. Use Voyageur Pharmaceuticals Coefficient Of Variation of 822.47, risk adjusted performance of 0.0987, and Variance of 130315.54 to evaluate company specific risk that cannot be diversified away. Voyageur Pharmaceuticals holds a performance score of 9 on a scale of zero to a hundred. The entity has a beta of 5.93, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Voyageur Pharmaceuticals will likely underperform. Use Voyageur Pharmaceuticals market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and kurtosis , to analyze future returns on Voyageur Pharmaceuticals.
Auto-correlation | 0.00 |
No correlation between past and present
Voyageur Pharmaceuticals has no correlation between past and present. Overlapping area represents the amount of predictability between Voyageur Pharmaceuticals time series from 22nd of December 2025 to 6th of January 2026 and 6th of January 2026 to 21st of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Voyageur Pharmaceuticals price movement. The serial correlation of 0.0 indicates that just 0.0% of current Voyageur Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Voyageur Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Voyageur Pharmaceuticals pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Voyageur Pharmaceuticals' pink sheet expected returns. We can calculate the autocorrelation of Voyageur Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Voyageur Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Voyageur Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Voyageur Pharmaceuticals pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Voyageur Pharmaceuticals pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Voyageur Pharmaceuticals pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Voyageur Pharmaceuticals Lagged Returns
When evaluating Voyageur Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Voyageur Pharmaceuticals pink sheet have on its future price. Voyageur Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Voyageur Pharmaceuticals autocorrelation shows the relationship between Voyageur Pharmaceuticals pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Voyageur Pharmaceuticals.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Voyageur Pink Sheet
Voyageur Pharmaceuticals financial ratios help investors to determine whether Voyageur Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Voyageur with respect to the benefits of owning Voyageur Pharmaceuticals security.